Financial Ratios

JOHNSON PHARMACARE LTD.

NSE : NABSE : 532154ISIN CODE : INE560F01022Industry : TradingHouse : Private
BSE0.79-0.01 (-1.25 %)
PREV CLOSE ( ) 0.80
OPEN PRICE ( ) 0.79
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 665532
TODAY'S LOW / HIGH ( )0.79 0.79
52 WK LOW / HIGH ( ) 0.451.38
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)-0.020.000.00-0.020.00
   CEPS(Rs)-0.020.000.000.00
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)1.041.0611.6311.6311.64
   Tax Rate(%)2.8528.0526.000.000.00
Margin Ratios
   Core EBITDA Margin(%)-52.574.130.21-1.19
   EBIT Margin(%)-52.574.130.21-1.19
   Pre Tax Margin(%)-52.614.120.21-1.19
   PAT Margin (%)-51.112.960.15-1.19
   Cash Profit Margin (%)-51.112.960.15-1.19
Performance Ratios
   ROA(%)-2.160.160.00-0.15-0.02
   ROE(%)-2.240.170.00-0.16-0.02
   ROCE(%)-2.260.230.00-0.15-0.02
   Asset Turnover(x)0.040.050.010.000.02
   Sales/Fixed Asset(x)
   Working Capital/Sales(x)-2.59-74.160.150.000.18
Efficiency Ratios
   Fixed Capital/Sales(x)0.000.000.000.00
   Receivable days0.00152.68624.34365.00
   Inventory Days0.000.000.000.00
   Payable days182.500.00
Valuation Parameters
   PER(x)0.00667.011272.730.000.00
   PCE(x)-18.31733.7111923.01-63.72-1280.29
   Price/Book(x)0.421.220.240.100.24
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)10.1121.9219.0216.73
   EV/Core EBITDA(x)-19.23530.929109.98-67.51-1407.45
   EV/EBIT(x)-19.23530.929109.98-67.51-1407.45
   EV/CE(x)0.431.190.240.110.26
   M Cap / Sales9.3621.7418.4215.22
Growth Ratio
   Net Sales Growth(%)-22.56329.37-100.00
   Core EBITDA Growth(%)-1086.278388.78101.73-739.5582.49
   EBIT Growth(%)-1086.278388.78101.73-739.5582.49
   PAT Growth(%)-1435.478135.39101.28-739.5582.50
   EPS Growth(%)-1436.61779.09101.09-741.3482.50
Financial Stability Ratios
   Total Debt/Equity(x)0.030.010.010.010.03
   Current Ratio(x)0.000.968.604858.395142.00
   Quick Ratio(x)0.000.968.604858.395142.00
   Interest Cover(x)-1660.63449.00
   Total Debt/Mcap(x)0.080.010.050.110.12

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.